TrialEuropean urology oncology2023

Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314.

Yi-Tsung Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.